Scientists have discovered the mechanism which allows the superbug Methicillin Resistant Staphylococcus aureus (MRSA) to become highly resistant to antibiotics, paving the way for new approaches to ...
An antibiotic developed some 80 years ago before being abandoned and forgotten could again offer exciting new solutions, this ...
Researchers say understanding how bacteria can survive antibiotic treatment will help them develop new ways to treat the potentially deadly superbug ...
Thioredoxin Systems AB (TXN Systems), a pharmaceutical company developing a first-in-class antibiotic for multidrug-resistant urinary tract infections, today announced the close of an approximate SEK ...
To give you something new to worry about, we pulled from the scariest thing we can think of — the state of the world — and ...
A team from Wake Forest University School of Medicine and Atrium Health has been approved for a $2.5 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to help improve ...
Rather than an acute illness with high fever and respiratory distress, atypical pneumonia progresses more slowly, with ...
EbsArgent targets urinary tract infections, with early indications of efficacy against many species of multidrug-resistant bacteria STOCKHOLM, Oct. 30, 2024 /PRNewswire/ -- Thioredoxin ...
Walking pneumonia has been on the rise nationwide, mainly among kids. The bacteria can linger for weeks, but is treatable ...
UCD and University of Sheffield researchers have made a discovery relating to mechanisms that allow MRSA to become highly resistant to antibiotics.